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Abstract
Single domain antibodies are recombinantly expressed functional antibodies devoid of light
chains. These binding elements are derived from heavy chain antibodies found in camelids
and offer several distinctive properties for applications in biotechnology such as small size,
stability, solubility, and expression in high yields. In this study we demonstrated the potential
of using single domain antibodies as capturing molecules in biosensing applications. Single
domain antibodies raised against green fluorescent protein were anchored onto biosensor
surfaces by using several immobilization strategies based on Ni2+:nitrilotriacetic acid-poly-
histidine tag, antibody-antigen, biotin-streptavidin interactions and amine-coupling chemis-
try. The interaction with the specific target of the single domain antibodies was
characterized by surface plasmon resonance. The immobilized single domain antibodies
show high affinities for their antigens with KD = 3–6 nM and outperform other antibody part-
ners as capturing molecules facilitating also the data analysis. Furthermore they offer high
resistance and stability to a wide range of denaturing agents. These unique biophysical
properties and the production of novel single domain antibodies against affinity tags make
them particularly attractive for use in biosensing and diagnostic assays.
Introduction
Single domain antibodies, also referred to as nanobodies (Ablynx) or VhH, were discovered in
the serum of camelids by Hamers-Casterman and co-workers in 1993 [1]. They represent a
unique type of functional antibodies that lack the light chains, while preserving the antigen-
binding properties of conventional antibodies. Single domain antibodies display exclusive
properties [2,3,4] and have been shown to have great potential in a variety of basic research
work (i.e. localization of proteins in cells, stabilizing agents in protein structural studies) [3],
biotechnological [5,6] and medical applications [7], disease diagnostics [2,8,9], and therapeu-
tics [10]. Single domain antibodies recognize their antigens with high specificity and affinities
similar to IgG antibodies, but thanks to their small size (molecular weight ~13 kDa) they
can bind epitope inaccessible to twelve times larger standard antibodies (molecular weight
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~150 kDa) [4,11]. Nanobodies exist as monomers, have high solubility and have a low tendency
to aggregate because hydrophobic residues of the VhH surface are substituted by more hydro-
philic residues [2,11]. Single domain antibodies are resistant to extreme pH, heat denaturation,
proteolysis, solvents and detergents [12,13,14,15]. They can be produced in high expression
yields in heterologous systems such as bacteria or yeast and are very easy to purify and handle
[11]. All these properties make them very attractive capturing molecules for biosensor and di-
agnostic applications. However, upon immobilization, single domain antibodies might present
different properties from the ones observed in solution [16] and their potential as capturing
agents still needs to be characterized in details.
Over the last years, Surface Plasmon Resonance (SPR) biosensors have been widely used to
monitor biomolecular interactions due to their high sensitivity, reproducibility and label-free
capabilities. Previous reports based on SPR experiments have determined kinetic binding pa-
rameters of single domain antibodies for their antigens [17,18,19] and demonstrated the utility
of nanobodies for detection of tumor markers such as prostate specific antigen (PSA) at clinical
relevant concentrations [20,21].
Here we present a detailed SPR study of the interaction between a Green Fluorescent Pro-
tein (GFP) and a single domain antibody derived from a llama single domain antibody
(GFP-Nb) [3,22,23,24]. The GFP:GFP-Nb complex was chosen as model system because the
nanobody can serve as a universal adapter, allowing the immobilization of any GFP chimeric
protein on biosensor surfaces. In fact cloning, expression and purification of GFP-fusion pro-
teins can be easily accomplished by using one of the many commercially available vectors for
production of GFP chimeric proteins [25]. Furthermore by using the fluorescence properties of
GFP, the GFP:GFP-Nb system can be used to study localization and dynamic interactions of
proteins in vivo [3,24]. The 13 kDa GFP-Nb folds in a barrel-shaped structure (2.5 nm x 4.5
nm) and it has been shown to enable efficient separation of GFP-tagged proteins from cell ex-
tracts [23,26]. The GFP-Nb recognizes specifically only GFP derivatives such as wild-type GFP,
eGFP, Yellow Fluorescent Protein (YFP), eYFP; while it does not bind other red fluorescent
proteins derived from Anthozoa (i.e. Discosoma Red Fluorescent Protein (DsRed), mFruit se-
ries) [22,23,27]. The molecular structure of the GFP:GFP-Nb complex has been determined by
X-ray crystallography and isothermal titration calorimetry (ITC) experiments have illustrated
the thermodynamics of the complex formation in solution [27].
In this study, we have demonstrated and compared several proof-of-principle immobiliza-
tion strategies of nanobodies on SPR biosensor surfaces, based on directional non-covalent
Ni2+:nitrilotriacetic acid (NTA)-polyhistidine tag and antibody-antigen interactions, non-co-
valent randomly-oriented interactions between in vivo biotinylated nanobodies and streptavi-
din, and covalent coupling between the amino groups of the protein and the carboxylic groups
of the biosensor surface. By using these immobilization methods we examine the performance
of several commercial SPR chips, determine the kinetic binding constants of the single domain
antibodies for their antigens on the different surfaces and compare them with those of classical
monoclonal antibodies. In addition we illustrate the advantages of the nanobodies both as cap-
turing agents and ligands over other antibodies. We also investigate the stability of the nanobo-
dies to several harsh conditions (high temperature, extreme pH values and high ionic
strength).
Materials and Methods
Reagents
HEPES, NaCl, EDTA, tween 20, NiCl2, glycine, biotinamidohexanoic acid N-hydroxysuccini-
mide ester (Bt-NHS) and all the materials used for protein expression and purification were
Single Domain Antibodies for High Quality SPR Studies
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purchased from Sigma-Aldrich (Denmark). 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
hydrochloride (EDC), N-hydroxysuccinimide (NHS), ethanolamine-HCl, sensor chips CM5,
NTA and CAP and monoclonal anti-polyhistidine antibody were from GE Healthcare (Den-
mark). Single domain antibodies against GFP presenting a six histidine-tag at the C-terminal
were obtained from Chromotek GmbH (Germany) as GFP-Trap, biotin-labelled monoclonal
anti-GFP antibodies were from Novus Biologicals (Denmark), monoclonal anti-GFP antibod-
ies were from Invitrogen (Denmark).
Production of his-eGFP and GFP
The gene encoding his-eGFP and GFP cloned respectively in pET and pJF plasmids and trans-
formed in E. Coli BL21 (DE3) were obtained from Addgene [28,29]. Cells containing the plas-
mids were separately inoculated in 10 mL of Luria Bertani Broth (LB-broth) medium
supplemented with 100 μg/mL ampicillin and grown overnight at 37°C (250 rpm). The over-
night cell cultures were then diluted 1:100 in LB-broth medium supplemented with 100 μg/mL
ampicillin and grown at 37°C in shaking flasks (250 rpm). Cultures were grown until the
OD600 reached 0.6–0.8 and then protein overexpression was induced by addition of 0.5 mM
isopropyl-h-D-thiogalactopyranoside (IPTG) at 30°C for 3 hours. Cells were harvested by cen-
trifugation at 3000 x g for 15 min at 4°C; the cell pellet was suspended in 10 mL of cold phos-
phate buffer saline (PBS) buffer pH 7.4, 1 mM phenylmethanesulfonylfluoride (PMSF) and
1 mg/mL lysozyme. After 30 min incubation on ice, the suspension was first sonicated for
2 min and then centrifuged at 14000 x g for 45 min at 4°C. The supernatant was collected and
stored at -20°C. The his-eGFP was purified by immobilized metal affinity chromatography
(IMAC) on a His-Trap column (GE Healthcare), and gel filtration on a Superdex 200 10/300
GL column (GE Healthcare). The protein solution was applied on the His-Trap column loaded
with nickel and equilibrated with 20 mM sodium phosphate pH 7.4, 0.5 M NaCl, 20 mM imid-
azole. The column was washed with 20 mM sodium phosphate pH 7.4, 0.5 M NaCl, 100 mM
imidazole and the protein was eluted with 20 mM sodium phosphate pH 7.4, 0.5 M NaCl, 500
mM imidazole. The protein solution was further purified on a gel filtration column equilibrat-
ed with 10 mM sodium phosphate pH 7.4, 50 mM NaCl. Purification of GFP was performed
by ion exchange chromatography on a Q Sepharose High Performance (GE Healthcare) devel-
oped with a linear gradient of 0–500 mMNaCl in 10 mM tris buffer pH 8.0. Fractions contain-
ing GFP were then concentrated by ultrafiltration with Amicon Ultra 15 mL centrifugal filter
units 10 kDa MWCO (EMDMillipore, Denmark) and purified on a Superdex 200 10/300 GL
column. Degree of purity of both his-eGFP and GFP proteins was evaluated to be at least 95%
based upon sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis.
Protein concentration was spectroscopically determined using an extinction coefficient at
488 nm (ε488) of 55 mM
-1cm-1 [30]. The protein solutions were either used immediately or
stored at -20°C.
Biotinylation of the GFP-Nb
Bt-NHS was dissolved in deionized water (18.2 MO cm at 25°C) and then added to the
GFP-Nb at a molar ratio of 2:1. The reaction mixture was incubated at 25°C for 60 min with
shaking and then the nanobody was separated from free Bt-NHS by ultrafiltration with Ami-
con Ultra 0.5 mL centrifugal filter units (3 kDa MWCO). The final concentration of the protein
was evaluated by measuring the sample absorbance at 280 nm and using an extinction coeffi-
cient of 27 mM-1 cm-1.
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SPR experiments
SPR assays were performed using a BIAcore X100 instrument (GE Healthcare) at a constant
temperature of 25°C. Several SPR commercial chips from Biacore (CM5, NTA, CAP and CM5
chip functionalized with anti-polyhistidine) were used. Each chip consists of two flow cell; one
of them (flow cell 1) is used as a control while the ligand is immobilized on the second one
(flow cell 2). Here data are presented as the difference between the signal collected in flow cell 2
and the signal in flow cell 1. At least a 1000-fold range of protein concentrations injected in
random order was investigated in each experiment, and all the experiments were replicated at
least twice. All sensorgrams were processed and analyzed by using the BIAcontrol and BIAeva-
luation software (GE Healthcare). Semi-logarithmic curves of the binding equilibrium response
versus the analyte concentration were evaluated by non-linear regression of the Hill equation
to yield equilibrium dissociation constants (KD). Kinetic rate constants for the interaction GFP:
GFP-Nb and GFP:anti-GFP were determined by fitting the corrected sensorgrams to a 1:1
binding model (Langmuir isotherm) using the non-linear least-squares data analysis integrated
in the BIAevaluation software. Errors were evaluated as the standard deviation of
the measurements.
NTA Chip. Immobilization on the NTA chip was performed by activating the surface of
flow cell 2 with a 60 s injection of 0.5 mM NiCl2 in 10 mMHEPES pH 7.4, 0.15 M NaCl,
50 μM EDTA, 0.05% tween 20 (NTA running buffer), stabilizing both the cells for 300 s and
then applying the his-tagged proteins diluted in running buffer to the flow cells for 150 s. The
dissociation of the ligand from the surface was monitored for 400 s and then the surface was re-
generated by a 60 s injection of 10 mMHEPES pH 7.4, 0.15 M NaCl, 0.35 M EDTA, 0.05%
tween 20 (NTA regeneration buffer). Flow rate during all the experiments was 10 μl/min. The
affinity of the GFP for the GFP-Nb was probed by immobilizing ~3 nM of the ligand
(GFP-Nb) on flow cell 2 (binding of 120 s and surface stabilization of 300 s) and then applying
the analyte (GFP) on both flow cells for 150 s and recording its dissociation for 400 s. The cycle
ended with the regeneration of the surface (60 s injection) and a stabilization period of 300 s.
Flow rate was 30 μl/min.
CM5 Chip. In order to determine the best conditions for antibodies immobilization, a pH
scouting analysis was performed using eight different buffer solutions (pH values ranging from
4.0 to 6.0) and 50 μg/mL antibodies concentration. Anti-polyhistidine antibody and anti-GFP
antibody diluted in 10 mM sodium acetate pH 4.6 to a concentration of 5 μg/mL and GFP-Nb
diluted to a concentration of 50 μg/mL in 10 mM acetate pH 5.4 were covalently immobilized
on the surface of flow cell 2 of different CM5 chips using primary amine-coupling methods.
The carboxyl groups of the dextran matrix were activated by a 7 min injection of a 1:1 mixture
of 0.4 M EDC and 0.1 M NHS, then the proteins were injected on the surface for 7 min and the
remaining NHS-ester active groups were deactivated by a 7 min injection of 1 M ethanolamine
HCl pH 8.5. Anti-polyhistidine and anti-GFP antibody were immobilized to a level of ~10000
Resonance Unit (R.U.), while GFP-Nb were immobilized to a level of ~2500 R.U.. The binding
experiments started with a 60 s stabilization period in 10 mMHEPES pH 7.4, 0.15 M NaCl,
0.05% tween 20 (CM5 running buffer) that was followed by the capture of the ligand with a
120 s injection and its dissociation was followed for 400 s. The analyte was then injected on
both flow cells for 150 s and its dissociation was recorded for 400 s. The cycle ended with the
regeneration of the surface (60 s injection of 10 mM glycine pH 2.0) and a stabilization period
of 120 s. The flow rate during the experiments was 30 μl/min.
CAP chip. With regards the experiments where the affinity of the biotin-tagged proteins
for the surface was probed, the “Biotin CAPture reagent” (GE Healthcare) was flowed on flow
cell 2 with a 300 s injection at a flow rate of 2 μl/min and stabilized for a period of 300 s. The
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biotinylated protein diluted in 10 mMHEPES pH 7.4, 0.15 M NaCl, 50 μM EDTA, 0.05%
tween 20 (CAP running buffer) was then flowed on both flow cells for 150 s and its dissociation
was recorded for 400 s (flow rate was 10 μl/min). The cycle ended with the regeneration of the
surface (120 s injection of 6 M guanidine-HCl and 0.25 M NaOH, CAP regeneration buffer)
and a stabilization period of 120 s. In the experiments where the affinity of the GFP for the bio-
tinylated ligand was probed, the surface of both the flow cells was activated (300 s injection of
CAPture reagent, flow rate 2 μl/min), and then the ligand solution in CAP running buffer was
applied to flow cell 2 for 120 s and the surface was stabilized for 300 s (the concentration of the
ligand was 5 nM for the GFP-Nb and 60 nM for the anti-GFP). Following immobilization of
the ligand, the analyte was injected on both flow cells for 150 s and its dissociation was re-
corded for 400 s (flow rate was 30 μl/min). The cycle ended with the regeneration of the surface
(120 s injection of CAP regeneration buffer) and a stabilization period of 300 s.
GFP-Nb stability experiments. In the stability experiments the GFP-Nb were either dilut-
ed in NTA running buffer, kept at different temperatures for 30 min and allowed to recover at
room temperature for 30 min (temperature range from 25°C to 100°C), or diluted in NTA run-
ning buffer corrected to different pH values by adding 37% HCl or 2 M NaOH solution (pH
range from 4.0 to 10.5). The GFP was diluted in NTA running buffer containing different con-
centrations of NaCl (0 mM, 150 mM, 300 mM, 500 mM and 1 M). The GFP-Nb was then im-
mobilized on the activated flow cell 2 of the NTA chip and the same conditions described in
the “NTA Chip” sub-section were used to probe the binding of the GFP-Nb to the Ni:NTA sur-
face and the interaction between GFP-Nb and GFP. The experiments were performed using
the NTA chip because the biosensor surface could be easily regenerated by complete removal
of the nanobodies allowing the re-use of the sensor chip.
Results and Discussion
Interaction of GFP-Nb with SPR biosensor surfaces
GFP-Nb was immobilized on three different commercial SPR biosensor chips (Biacore) namely
CM5, NTA and CAP chip. The CM5 chip consists of a gold surface covered with a carboxy-
methyl-terminated dextran layer. The NTA chip is a CM5 chip with pre-immobilized NTA
groups where his-tagged molecules can be immobilized viaNi2+-NTA chelation. The CAP
chip consists of a CM5 sensor surface functionalized with single strand DNA (ss-DNA) oligo-
nucleotides to which streptavidin conjugated with the complementary ss-DNA oligonucleotide
can be coupled. Biotinylated molecules can then be attached to the biosensor surface. SPR
based analysis of the binding of the GFP-Nb to the three different biosensors indicated a strong
and specific interaction of the protein for all the surfaces (Fig 1). The SPR traces showed re-
sponses ranging from baseline signals (at ~1 nM) to saturation of the surface (at 1 μM). The
GFP-Nb showed a very low non-specific binding to the reference surfaces; even at high concen-
trations the signal measured on the reference surfaces was less than 1% of the signal measured
on the respective active surfaces. The response of the chips to the addition of nanobody was
very reproducible over different cycles (S1 Fig) and the nanobody could be completely removed
from the surface by using the regeneration conditions described in the methods section. How-
ever, while the NTA chip allowed running more than a thousand experimental cycles, the CAP
and the CM5 chip functionalized with the anti-polyhistidine allowed ~100 cycles due to the
degradation of the oligonucleotides and the antibodies immobilized respectively on the two
surfaces. Furthermore, due to the presence of a higher number of binding sites, the amount of
proteins that could be immobilized on the NTA chip was almost three times the one that could
be immobilized on the other two surfaces (Fig 1).
Single Domain Antibodies for High Quality SPR Studies
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A qualitative analysis of the sensorgrams indicated that the affinity of the GFP-Nb for the
surfaces follows the order CAP-chip> anti-polyhistidine> Ni:NTA. In particular, while the
dissociation of the biotinylated nanobody from the streptavidin-conjugate surface does not de-
pend on the amount of immobilized protein, the nanobody tends to dissociate from the other
surfaces at concentrations higher than 50 nM. Fitting of the SPR sensorgrams to a 1:1 binding
model revealed a kon = (1.6 ± 0.4) x 10
6 1/Ms and a koff = (1.2 ± 0.3) x 10
–2 1/s for the interac-
tion of the nanobody with the Ni:NTA surface and a kon = (1.0 ± 0.3) x 10
6 1/Ms and a koff =
(8.8 ± 1.1) x 10–4 1/s for the interaction of the nanobody with the anti-polyhistidine surface (S2
Fig).
The GFP-Nb end-point response data fitted a simple monovalent interaction with the three
surfaces (Fig 2 and S3 Fig). The calculated binding constants were KD = 120 ± 14, 38 ± 3 and
30 ± 5 nM for the Ni:NTA, anti-polyhistidine and streptavidin surface. These values are in
close agreement to others previously reported for the interaction of biotin-tagged molecules
with streptavidin-functionalized surfaces [31]. However, the GFP-Nb interacts more strongly
with the NTA and CM5 SPR chips than another reference polyhistidine-tagged protein (his-
eGFP, S1 and S4 Figs). The evaluated equilibrium dissociation constants of his-eGFP were
420 ± 50 nM and 400 ± 33 nM for the Ni:NTA and the anti-polyhistidine surface, respectively.
Both the KDs are higher than the ones evaluated for the GFP-Nb and this is mainly due to a
higher koff; in particular the koff for the anti-polyhistidine surface is (4.8 ± 0.1) x 10
–2 1/s (S6
Fig). The differences in affinity could be explained by considering the position of the polyhisti-
dine tag on the C-terminal of the nanobody that is more accessible to the binding sites on the
surface than the one of the his-eGFP (S7 Fig).
The GFP:GFP-Nb complex
The capture of the GFP-Nb on the different surfaces was followed up by the study of the inter-
action between the nanobody and the GFP (Fig 3). The GFP-Nb was immobilized onto the dif-
ferent surfaces at a low density (~50 R.U.), and the high efficiency reached by the
immobilization strategies (Fig 1) allowed the use of very low concentrations of GFP-Nb (less
than 3 nM). GFP was observed to bind with a high affinity to the immobilized partner on all
the three surfaces. Very low non-specific binding of GFP to the reference surfaces was observed
(less than 1% of the specific signal measured on the activated flow cell 2). The kinetic parame-
ters were determined by fitting the SPR data to a simple interaction model (Table 1); although
Fig 1. Binding of GFP-Nb to SPR biosensor surfaces. The SPR sensorgrams show the interaction between the GFP-Nb and a NTA surface activated with
Ni2+ ions (A), a CM5 chip functionalized with anti-polyhistidine antibodies (B) and a CAP-chip sensor surface bearing streptavidin free binding sites (C).
Depicted sensorgrams were obtained for GFP-Nb concentration of 1, 5, 10, 35, 50, 100, 250, 500, 1000, 1500 nM (from bottom to top curve).
doi:10.1371/journal.pone.0124303.g001
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the kon of the binding complex was nearly identical on the three surfaces (kon = (1.1 ± 0.5) x
106 1/Ms, (1.0 ± 0.4) x 106 1/Ms, (1.3 ± 0.4) x 106 1/Ms for the nanobody immobilized on Ni:
NTA, anti-polyhistidine and streptavidin), the koff was significantly higher on the Ni:NTA chip
Fig 2. Endpoint response of the reference subtracted binding curves describing the interaction
between the GFP-Nb and the different surfaces as function of GFP-Nb concentration. The red, blue and
black squares are the raw data for the Ni:NTA, the anti-polyhistidine and the CAP chip respectively, and the
lines are the best fit of the data set to the Hill’s equation (R2 = 0.99). As choosing a Hill’s coefficient equal to 1
did not produce a good fit of the data describing the interaction between the GFP-Nb and the anti-
polyhistidine and the CAP-chip (S2 Fig), a Hill’s coefficient of 2 was set for these lines.
doi:10.1371/journal.pone.0124303.g002
Fig 3. GFP:GFP-Nb complex. Binding of GFP to GFP-Nb immobilized on Ni:NTA (A), anti-polyhistidine antibody on CM5 (B) and streptavidin on CAP chip
(C). Black lines are raw data and the red lines are the fitting to a 1:1 binding model. Depicted sensorgrams were obtained for GFP concentration of 0.1, 0.5, 1,
5, 10, 50, 100, 200, 500, 1000 nM (from bottom to top curve).
doi:10.1371/journal.pone.0124303.g003
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((7.1 ± 1.1) x 10–4 1/s) than on the antibody and the streptavidin functionalized surfaces
((2.9 ± 0.4) x 10–4 1/s, (9.1 ± 1.3) x 10–5 1/s, respectively). His-tagged ligand release from Ni:
NTA surface is frequently observed [32] and this phenomenon can explain the difference in
the evaluated koff. These results suggest that the streptavidin/biotin based immobilization
yielded the best results in terms of ligand stability and analyte detection limit (50 pM). Howev-
er, in our case the biosensor surface affected the measurements only to a minor extent. In fact,
the affinity of the GFP:GFP-Nb interaction determined from a simple fitting of the end-point
response to a binding isotherm revealed KD values very similar for all the surfaces (Fig 4). The
affinity of the interaction was determined to be slightly higher when the nanobody was immo-
bilized on the CAP chip (KD = 3.7 ± 0.3 nM) than on the anti-polyhistidine and Ni:NTA chip
(KD = 5.5 ± 0.5 nM and KD = 6.1 ± 0.9 nM, respectively) (Table 1). These results show that,
while the immobilization method can affect measurements of binding affinities to a minor ex-
tent and a stable coupling method based on streptavidin-biotin interactions is very desirable,
Table 1. Determination of the kinetic parameters kon and koff and affinities KD of the GFP:GFP-Nb interaction on different biosensor chip surfaces.
kon (106/Ms)a koff (10-4/s) a KD (nM) b
Ni:NTA chip 1.1 ± 0.5 7.1 ± 1.1 6.1 ± 0.9
Anti-polyhistidine antibody CM5 chip 1.0 ± 0.4 2.9 ± 0.4 5.5 ± 0.5
Streptavidin on CAP chip 1.3 ± 0.4 0.9 ± 0.1 3.7 ± 0.3
a The kinetic parameters kon and koff were determined by ﬁtting the SPR data to a 1:1 interaction model (Fig 3).
b The KD parameters of the GFP:GFP-Nb interaction were determined from a ﬁtting of the end-point response to a binding isotherm (Fig 4).
doi:10.1371/journal.pone.0124303.t001
Fig 4. Endpoint response of the reference subtracted binding curves of the GFP:GFP-Nb interaction
as function of GFP concentration. The red, blue and black squares are the raw data collected for the Ni:
NTA, the anti-polyhistidine and the CAP chip respectively, and the lines are the best fit of the data set to the
Hill’s equation (R2 = 0.99).
doi:10.1371/journal.pone.0124303.g004
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easier-to-regenerate surfaces such as the one of the NTA chip can also be very convenient for
initial experiments where a large variety of parameters usually needs to be screened.
We also noticed that the in vitro biotinylation of the nanobody did not affect its binding
properties. This is somehow counterintuitive because the biotin groups should be randomly
tethered to the free amino groups accessible on the surface of the protein resulting in different
orientations of the protein on the streptavidin surface and in only a fraction of the nanobody
being active for antigen recognition. On the opposite, the histidine-based immobilization
methods should allow an oriented capture of the nanobody on the surface due to the presence
of the histidine tag on the nanobody C-terminal end. However, in the case of the GFP-Nb, all
the lysine residues lie on the surface close to the C-terminal at the antipode of the paratope (S8
Fig). This resulted in an optimal orientation of the immobilized nanobody on the SPR strepta-
vidin sensor with its binding pocket oriented towards the solution. Furthermore the presence
of the amino-space linker of the Bt-NHS minimizes steric hindrance effects of the dextran ma-
trix and leads to a more pronounced exposure of the nanobody towards the solute enhancing
its antigen-capturing properties.
The KD of the GFP:GFP-Nb interaction determined by SPR investigations matched well
with the results previously obtained for the same complex by interferometry (KD = 1.4 nM
[27]) or for similar complexes by SPR (KD = 1–10 nM [14]). In order to compare the binding
properties between nanobodies and classical antibodies, a biotinylated monoclonal anti-GFP
antibody was also immobilized on a CAP chip and its capturing properties were tested by SPR
(S9 Fig). Although similar densities of antibody and nanobody were immobilized on the sur-
face (~4 fmol/mm2), the nanobody could detect lower concentration of GFP than the antibody
(50 and 500 pM, respectively). Furthermore the affinity of the immobilized antibody for free
GFP (KD = 33 ± 5 nM, S10 Fig) was one order of magnitude lower than the one measured for
the nanobody. This is probably due to the random orientation of the immobilized antibody
that provided a lower accessibility of the binding pocket compared to the nanobody. Further-
more, due to avidity effects resulting from the antibodies bivalency, the sensorgrams could not
be fitted by a simple interaction model, but a heterogeneous ligand model had to be used (S11
Fig). These results clearly illustrate the advantages of the nanobodies over classical antibodies
as attractive partners in biosensor applications.
GFP-Nb as recognition motif for GFP affinity tags
Having identified the properties of the interaction between the GFP-Nb and its antigen, we in-
vestigated how well it would function as a capturing molecule in SPR assays. The GFP-Nb di-
luted in sodium acetate buffers with pH varying between 4.0 and 6.0 was injected onto the
surface of a CM5 chip (S12 Fig). The optimum conditions for immobilization of the protein
were obtained using a solution of pH 5.4 that is more neutral than the one that needs to be
used to immobilize anti-GFP antibody on a CM5 surface (S13 Fig). The GFP-Nb was then im-
mobilized on the surface of the CM5 chip by covalent coupling of the free amino groups of the
protein surface and the activated carboxylic groups of the CM5 dextran matrix. The amount of
nanobody immobilized onto the CM5 surface (~2500 R.U.) corresponded to ~200 fmol/mm2
that is more than three times the amount of anti-GFP antibody immobilized in a similar fash-
ion on a CM5 chip (~10000 R.U. corresponding to ~65 fmol/mm2).
Different concentrations of GFP were injected on the chip functionalized with the nanobody
(Fig 5); the maximum response achieved was 3400 R.U. that is ~75% of the theoretical maxi-
mum binding capacity of the functionalized surface for GFP. As for the streptavidin-mediated
immobilization, the presence of the lysine residues at the antipode of the binding sites leads to
a quasi-site-specific and to a highly active immobilization of the probe. On the opposite, the
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maximum amount of GFP that could be immobilized on the anti-GFP antibody functionalized
surface was ~700 R.U. that is only 21% of the evaluated theoretical value (S14 Fig). This value
is almost five times lower than the maximum binding capacity of the CM5 chip coupled with
GFP-Nb indicating that steric hindrance effects due to the large size of the antibodies, their
random immobilization and the possible loss of functionality during the coupling procedure
affect strongly their binding properties. In addition the GFP-Nb bound to the CM5 chip shows
a higher affinity for the GFP (KD = 9.6 ± 0.2 nM, S15 Fig) than the anti-GFP antibody coupled
to the same matrix (KD = 30.0 ± 0.2 nM, S16 Fig).
As these results indicated that the GFP-Nb could be a valid, superior alternative to large, bi-
valent anti-GFP antibodies as capturing molecules for GFP fusion proteins we also investigated
the stability of the immobilized nanobody. We first followed the dissociation of the GFP from
the capturing agent for 10 hs (S17 Fig). The results indicated a very low off rate (koff = 1.4 x
10–5 s-1) with less than 10% of the GFP being removed from the surface after 10 hs. Multiple cy-
cles of GFP injection and surface regeneration indicated that the GFP-Nb was strongly immo-
bilized onto the CM5 surface and that the functionalized chip could be re-used without any
significant loss or variation in binding signal (S18 Fig). Furthermore the regeneration of the
GFP-Nb-coupled CM5 surface with 10 mM glycine pH 2.0 removed less than 0.1% of immobi-
lized proteins per cycle. As efficient regeneration of the surface is fundamental for the develop-
ment of a capturing agent, several regeneration conditions were also tested. Results indicated
that only 10 mM glycine-HCl (pH 1 or 2) removed completely the GFP from the surface.
50 mMNaOH solution could partially regenerate the surface, while other commonly used re-
generation solutions (5 M NaCl, 4 MMgCl2, 0.5% SDS and 50% ethylene glycol) would not af-
fect the GFP-Nb:GFP complex (S19 Fig). This result is particularly interesting for interaction
studies between GFP fusion proteins and their binding partners. Conventional surface-based
Fig 5. Interaction of GFP with a CM5 surface functionalized with GFP-Nb.Depicted sensorgrams were
obtained for GFP-Nb concentration of 0.2, 0.5, 1, 2, 5, 7, 10, 15, 20, 50, 100, 200, 500, 1000 nM (from bottom
to top curve).
doi:10.1371/journal.pone.0124303.g005
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studies require relatively large amounts of both fusion proteins and partners because following
every binding event the biosensor surface is regenerated by removing both the proteins. On the
opposite, in the case of GFP-tagged proteins immobilized on the GFP-Nb surface, only the in-
teraction partners could be removed by using one of the solutions listed above leaving the GFP
fusion protein free to interact with a new partner.
GFP-Nb stability
Many applications of single domain antibodies in biosensing technologies will eventually de-
pend on their stability and on the retention of their antigen-binding capacity in different condi-
tions (i.e. extreme pH, temperature and ionic strength, presence of solvents and/or
detergents. . .). Furthermore the surface-immobilized nanobodies need to be robust and resist
to multiple regenerations conditions in order to reduce the overall cost of the biosensors. Previ-
ous experiments have demonstrated that nanobodies retain most of their properties when ex-
posed to harsh conditions in solution [12,13,14,15,33]. Here we probed the antigen-binding
properties of the nanobodies under three extremely different denaturing conditions, using tem-
perature, chemicals and salt.
We started by examining the thermal stability of the GFP-Nb by monitoring its interaction
with GFP by SPR after being heated for 30 min and cooled at room temperature. Fig 6 shows
the sensorgrams recorded for the GFP:GFP-Nb interaction with the nanobody being incubated
at several temperatures (range 25°C—100°C) before immobilization on the Ni:NTA surface.
The thermal shock did not affect the nanobody ability to bind to the surface nor its interaction
with the GFP (Rmax = 47.6 ± 1.5); the evaluated affinities were identical within the error for all
the temperature range (kon = (1.5 ± 0.1) x 10
6 1/Ms, koff = (6.3 ± 0.2) x 10
–4 1/s). These results
demonstrate that the single domain antibodies fully recover their biological activity after a
complete thermal unfolding/refolding cycle even at temperatures higher than the melting tem-
perature (Tm = 60–80°C [14]). This is particularly interesting when compared to the poor
thermo-stability of classical antibodies for which incubation at temperature higher than their
Tm often results in exposure of inner hydrophobic pockets and in their aggregation
and precipitation.
The exceptional stability of the GFP-Nb was also evident from pH-induced unfolding exper-
iments. The protein samples, incubated overnight in NTA running buffer of pH values varying
between 4.0 and 10.5 and then immobilized on a Ni:NTA surface, were tested for their ability
to bind the antigen by SPR (S20 Fig). The nanobody was found to bind to the Ni:NTA ~50%
less at pH< 6 (S21 Fig). This is probably due to repulsion effects between the negatively
charged surface of the biosensor (pKa = 3.5) and some negative residues exposed on the protein
surface. However, upon immobilization, the nanobody retained its antigen-binding capacity
with association and dissociation constants very homogeneous over the all pH range (kon =
(1.4 ± 0.2) x 106 1/Ms, koff = (6.4 ± 0.8) x 10
–4 1/s).
Further experiments examined the effect of the buffer ionic strength on the antigen-nano-
body binding kinetics. SPR measurements demonstrated that incubating GFP with high con-
centrations of NaCl (up to 1 M) did not impair the nanobody ability to recognize its binding
partner (S22 Fig). The association and dissociation constants appear to be independent from
the NaCl concentration (kon = (1.5 ± 0.2) x 10
6 1/Ms, koff = (6.3 ± 0.5) x 10
–4 1/s). These results
seem to be a further indication that only hydrophobic interaction at the binding interface be-
tween the GFP-Nb and the GFP are responsible of the complex high affinity (residue Phe102 of
GFP-Nb interacts with Leu221, Ala206, and Phe223 of GFP and Trp47 of GFP-Nb interacts
with Val176 and Ser175 of GFP) [27].
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Our experiments demonstrate once more the remarkable stability and refolding properties
of the single domain antibodies that are particularly important in biosensor applications where
proteins need to be chemically modified to be attached to a solid support.
Conclusions
Over the last years several studies have demonstrated the use of single domain antibodies for
biotechnological applications. These proteins can be easily expressed in several hosts, are small
and more stable than conventional antibodies, have high solubility properties and high speci-
ficity and selectivity for their interaction partners. Here, we have investigated the properties of
a nanobody against GFP by using SPR; the achieved results are not limited to SPR applications,
but they can be easily applied to any other biosensing platform.
Fig 6. Effect of temperature on GFP-Nb stability. The sensorgrams illustrates the binding of 30 nM GFP to the GFP-Nb immobilized on a Ni:NTA surface.
Before immobilization, the nanobody had been heated at the temperatures indicated in the figure for 30 min and then allowed to cool down at room
temperature for 30 min. The inset shows a zoom of the sensorgrams recorded between 50 s and 250 s.
doi:10.1371/journal.pone.0124303.g006
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Robust immobilization of the nanobody can be successfully achieved on Ni:NTA and anti-
polyhistidine chips via his-tag, on streptavidin-functionalized surfaces via biotin tag or directly
on carboxylic-terminated surfaces by chemical coupling. We evaluate and compare the advan-
tages and the limitations of all these immobilization schemes to detect specific antigens; and
show that nanobodies outperform large classical antibodies in terms of both binding capacity
and affinities. Thanks to the presence of lysine residues at the antipode of the binding site, the
GFP-Nb can be immobilized in an oriented manner on the biosensor surface allowing for an
optimal configuration for efficient capture of the antigen of interest. Furthermore the GFP-Nb
shows a high stability; it can be strongly immobilized on the biosensor surfaces and resist a
wide variety of extreme conditions such as high temperature, solution of low or high pH and
high salt content.
Our results demonstrate that the GFP-Nb combines a series of favorable properties compat-
ible with the development of robust capturing tools with high sensitivity, selectivity and speci-
ficity. Any wild-type GFP, eGFP as well as YFP and eYFP-fusion proteins could be
immobilized on a surface functionalized with the GFP-Nb and the interaction with the binding
partner evaluated. Furthermore the availability and the development of novel nanobodies
against other affinity tags (i.e. GST, RFP, short peptides. . .) paves the way to a wide variety of
applications both in biosensing and diagnostics.
Supporting Information
S1 Fig. Reproducibility of the GFP-Nb immobilization. The sensorgrams show five runs of
immobilization of the GFP-Nb (35 nM) on the Ni:NTA surface and the replicates indicate the
reproducibility of the assay. The inset shows a zoom of the sensorgrams recorded between 150
s and 400 s.
(PNG)
S2 Fig. Binding of GFP-Nb to SPR biosensor surfaces. The SPR sensorgrams show the inter-
action between the GFP-Nb and a NTA surface activated with Ni ions (top), and a CM5 chip
functionalized with anti-polyhistidine antibodies (bottom). Black lines are raw data and the red
lines are the fitting to a 1:1 binding model. Depicted sensorgrams were obtained for GFP-Nb
concentration of 50, 100, 250, 500, 1000, 1500 nM (from bottom to top curve).
(TIF)
S3 Fig. Endpoint response of the reference subtracted binding curves of the GFP-Nb/sur-
faces interaction as function of GFP-Nb concentration. The red, blue and black squares are
the raw data for the Ni:NTA, the anti-polyhistidine and the CAP chip respectively, and the
lines are the best fit of the data set to the Hill’s equation (Hill’s coefficient set equal to 1).
(PNG)
S4 Fig. Binding of his-eGFP to Ni:NTA SPR biosensor surfaces. The SPR sensorgrams show
the interaction between his-eGFP and a NTA surface activated with Ni2+ ions. Depicted sen-
sorgrams were obtained for GFP-Nb concentration of 5, 10, 35, 50, 100, 250, 500, 1000 nM
(from bottom to top curve).
(PNG)
S5 Fig. Binding of his-eGFP to a CM5 chip functionalized with anti-polyhistidine antibod-
ies. Depicted sensorgrams were obtained for GFP-Nb concentration of 1, 5, 10, 35, 50, 100,
250, 500, 1000 nM (from bottom to top curve).
(PNG)
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S6 Fig. Anti-polyhistidine:GFP-Nb interaction. The normalized SPR sensorgrams show the
interaction between a CM5 chip functionalized with anti-polyhistidine antibodies and the
GFP-Nb (black line) and the his-eGFP (red line). Depicted sensorgrams were obtained for pro-
tein concentration of 35 nM.
(PNG)
S7 Fig. Structure of GFP-Nb. The protein ribbon structure is colored in red with the C-termi-
nal-where the poly-histidine tag is inserted—shown in blue (PDB, 3OGO).
(TIF)
S8 Fig. Structure of the GFP:GFP-Nb complex. GFP ribbon structure is colored in green, the
GFP-Nb is colored in red with the lysine residues highlighted as yellow spheres and the C-ter-
minal highlighted as blue spheres (PDB, 3OGO).
(TIF)
S9 Fig. GFP:anti-GFP complex. Binding of GFP to anti-GFP antibody immobilized on strep-
tavidin on CAP chip. Depicted sensorgrams were obtained for GFP concentration of 0.1, 0.5, 1,
5, 10, 50, 100, 200, 500, 1000 nM (from bottom to top curve).
(PNG)
S10 Fig. Endpoint response of the reference subtracted binding curves of the GFP:anti-
GFP antibody interaction as function of GFP concentration. The squares are the raw data
and the line is the best fit of the data set to the Hill’s equation (Hill’s coefficient set equal to 1).
(PNG)
S11 Fig. GFP:anti-GFP complex. Binding of GFP to anti-GFP antibody immobilized on strep-
tavidin on CAP chip. Black lines are raw data and the red lines are the fitting to a 1:1 binding
model. Depicted sensorgrams were obtained for GFP concentration of 0.1, 0.5, 1, 5, 10, 50, 100,
200, 500, 1000 nM.
(PNG)
S12 Fig. GFP-Nb pre-concentration scouting results. The protein was diluted in 10 mM sodi-
um acetate buffer with pH varying between 4.0 and 6.0. The binding increases as the pH in-
creases from 4.0 to 5.4. At pH higher than 5.7 the sensorgrams shows some dissociation after
the initial binding. The bound nanobody dissociated completely from the surface at the end of
the injection independently from the solution tested. The optimum pH for protein immobiliza-
tion is 5.4.
(PNG)
S13 Fig. Anti-GFP antibody pre-concentration scouting results. The protein was diluted in
10 mM sodium acetate buffer with pH varying between 4.0 and 6.0. The maximum binding is
achieved at pH values between 4.3 and 4.6; the binding decreases for pH values higher than 4.6.
The bound antibody dissociated completely from the surface at the end of the injection inde-
pendently from the solution tested. The optimum pH for protein immobilization is 4.6.
(PNG)
S14 Fig. Interaction of GFP with a CM5 surface functionalized with anti-GFP antibody.
Depicted sensorgrams were obtained for GFP-Nb concentration of 0.2, 0.5, 1, 2, 5, 7, 10, 15, 20,
50, 100, 200, 500, 1000 nM (from bottom to top curve).
(PNG)
S15 Fig. Endpoint response of the reference subtracted binding curves of the GFP:GFP-Nb
interaction as function of GFP concentration. GFP-Nb was immobilized onto a CM5 chip
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via amino-coupling. The squares are the raw data and the line is the best fit of the data set to
the Hill’s equation (Hill’s coefficient set equal to 1).
(PNG)
S16 Fig. Endpoint response of the reference subtracted binding curves of the GFP:anti-
GFP antibody interaction as function of GFP concentration. Anti-GFP was immobilized
onto a CM5 chip via amino-coupling. The squares are the raw data and the line is the best fit of
the data set to the Hill’s equation (Hill’s coefficient set equal to 1).
(PNG)
S17 Fig. Stability of the GFP:GFP-Nb interaction. The sensorgrams show a run of immobili-
zation of the GFP (10 nM) on the CM5 surface functionalized with the GFP-Nb. Dissociation
of the GFP was followed for 36000 s. The black curve is the raw data and the red line is the fit-
ting to a 1:1 binding model.
(PNG)
S18 Fig. Reproducibility of the GFP:GFP-Nb interaction. The sensorgrams show 50 runs of
immobilization of the GFP (10 nM) on the CM5 surface functionalized with the GFP-Nb. The
inset shows the Rmax value as a function of the cycle number.
(PNG)
S19 Fig. Effect of regeneration solutions on GFP:GFP-Nb interaction. The sensorgrams
show the immobilization of 10 nM GFP on a CM5 surface functionalized with the GFP-Nb fol-
lowed by regeneration with a series of solutions. While 10 mM glycine solution removed
completely the GFP from the surface and 50 mMNaOH removed partially the GFP, all the
other solutions did not affect the binding of GFP to the immobilized nanobody.
(PNG)
S20 Fig. Effect of pH on GFP-Nb stability. The sensorgrams illustrates the binding of 30 nM
GFP to the GFP-Nb immobilized on a Ni:NTA surface. Before immobilization, the nanobody
was diluted in NTA running buffer of several pH (range 4.0–10.5, see legend) and then applied
to the Ni:NTA surface.
(PNG)
S21 Fig. Effect of pH on GFP-Nb binding to Ni:NTA surface. The plot shows the maximum
response of the Ni:NTA chip for the nanobody as a function of the solution pH.
(PNG)
S22 Fig. Effect of ionic strength on GFP-Nb stability. The sensorgrams illustrates the binding
of the GFP-nanobody immobilized on a Ni:NTA surface to 30 nM GFP diluted in NTA run-
ning buffer with different concentration of NaCl (range 0.15 M-1.0 M, see legend).
(PNG)
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